MedTrace Logo

Leuprolide in Determining the Cause of Gonadotropin Deficiency

NCT00004426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-03-26

No results posted yet for this study

Summary

RATIONALE: The body's response to one injection of leuprolide may provide more information than the standard test for gonadotropin deficiency in determining whether the cause of gonadotropin deficiency is related to the hypothalamus or the pituitary gland.

PURPOSE: Randomized double-blinded clinical trial to study the effectiveness of leuprolide in determining the cause of gonadotropin deficiency.

Conditions

  • Hypogonadism

Interventions

DRUG

gonadotropin releasing hormone

DRUG

leuprolide

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Robert L. Rosenfield · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
9 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-08-31
Completion
1998-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004426 on ClinicalTrials.gov